超越COVID-19:下一代冠状病毒疫苗的承诺
Reshma Koolaparambil Mukesh1, Claude K Yinda1, Vincent J Munster1
1Laboratory of Virology, Division of Intramural Research, National Institutes of Health, Hamilton, MT, USA.
Npj viruses
|April 28, 2025
概括
开发针对冠状病毒 (CoV) 的广谱疫苗对于疫情准备至关重要. 本综述探讨了CoV特征,疫苗以及为新兴变种创造泛CoV疫苗的挑战.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 冠状病毒 (CoV) 已经造成了重大的全球健康危机,包括SARS-CoV-1,MERS-CoV和SARS-CoV-2 (导致COVID-19).
- 随着SARS-CoV-2变种的出现增加了传染性和免疫逃避,突显了改善流行病准备的迫切需要.
- 现有的疫苗针对的是特定的CoV菌株,因此需要对当前和未来的威胁进行更广泛的保护.
研究的目的:
- 为了提供冠状病毒特征和原型的全面概述.
- 审查目前针对各种Cov的疫苗.
- 讨论开发广泛的冠状病毒疫苗的努力和挑战,以应对疫情.
主要方法:
- 关于冠状病毒,它们的进化和疫苗开发的科学出版物的文献综述.
- 分析遗传学数据以了解CoV多样性.
- 综合有关现有和实验性Cov疫苗的信息.
主要成果:
- 冠状病毒表现出不同的基因特征,使疫苗开发复杂化.
- 目前的疫苗策略往往针对特定的CoV菌株,限制了交叉保护潜力.
- 目前正在进行重大研究,以开发泛冠状病毒疫苗.
结论:
- 广谱疫苗对于全球对冠状病毒的流行病准备是必不可少的.
- 克服基因复杂性是开发有效的泛CoV疫苗的关键.
- 持续的研究和开发对于应对不断变化的冠状病毒威胁至关重要.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.4K
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.1K
相关概念视频
Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
Vaccinations
43.0K
Overview
43.0K
Next-generation Sequencing
86.1K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.1K
Cross-reactivity
30.9K
Overview
30.9K
Viral Mutations
32.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.0K
Conjugated Proteins
18.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.1K
